title: New alternatives in anemia treatment: biosimilars and HIF stabilizers.
authors.forename: Mahesh
authors.initials: M
authors.lastname: Krishnan
authors.forename: Allen R
authors.initials: AR
authors.lastname: Nissenson
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D059451:Biosimilar Pharmaceuticals / Q000494:pharmacology*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000494:pharmacology*; D005060:Europe; D006397:Hematinics / Q000494:pharmacology*; D006801:Humans; D051793:Hypoxia-Inducible Factor 1 / Q000187:drug effects*; D007676:Kidney Failure, Chronic / Q000150:complications*; D011994:Recombinant Proteins / Q000494:pharmacology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D059451:Biosimilar Pharmaceuticals; D006397:Hematinics; D051793:Hypoxia-Inducible Factor 1; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa